ARS Pharmaceuticals
SPRY
#6100
Rank
NZ$1.59 B
Marketcap
NZ$16.17
Share price
-4.64%
Change (1 day)
-27.05%
Change (1 year)

Market capitalization of ARS Pharmaceuticals (SPRY)

Market cap: NZ$1.59 Billion

As of February 2026 ARS Pharmaceuticals has a market cap of NZ$1.59 Billion. This makes ARS Pharmaceuticals the world's 6100th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ARS Pharmaceuticals from 2022 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.59 B-17.71%
2025NZ$1.94 B4.46%
2024NZ$1.85 B123.52%
2023NZ$0.83 B-33.97%
2022NZ$1.25 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of ARS Pharmaceuticals was reported to be:

NZ$1.67 Billion
by Nasdaq info icon info icon
NZ$1.67 Billion
by CompaniesMarketCap info icon info icon